Exiris makes use of several platform technologies for target identification and validation. In addition, Exiris is developing its own antibody and drug conjugate technologies: Cancer stem cell platform, Drug conjugate technology and Antibody ID technology.
read moreTechnologies
Services
Exiris provides contract research services and collaborative development agreements using its innovative technology platforms: CSC Platform, Target ID, Drug-Conjugate platform, Custom human mAb production, Biomarker discovery and (…)
read moreJob opportunities
POSTGRADUATE OR YOUNG POSTDOC RESEARCHER IN THE FIRST 4-5 YEARS OF THEIR RESEARCH ACTIVITY
We are looking for a skilled bench scientist with a strong technical background in molecular biology, particularly phage display technologies, to join our Antibody ID Group.
read more18Feb
Exiris @ RaiNews24
RaiNews24, the national TV channel reporting on Italian news, interviews Gessica Filocamo, Exiris Director of Biology Labs, on their pharmaceutical research, as part of the.. Read More →
Contact us
Exiris srl
Laboratories:
Via Castel Romano 100
00128 Roma RM – Italy
Legal address:
Via Savona 6
00182 Rome – Italy
+39 06 50576530
www.exiris.it
info@exiris.it